UnitedHealth Group Incorporated

UNH Healthcare Healthcare Plans

UnitedHealth Group Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $447.6 billion, up 11.8% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 61.5%, free cash flow grew 62.7% and total debt fell 5.43%, each against the same quarter a year earlier. Member of the S&P 500 and Dow Jones; dividend growth for twenty-five consecutive years, revenue growth for ten.

377.76 0.76 −0.20%
Market cap
$339.1B
P/E
24.3×
Fwd P/E
23.3×
Dividend yield
2.40%
F-score
6/9
Altman Z
2.84
Beneish M
−2.41
Dividend safety
76/100
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
21.61 20.65 20.44 20.52 21.88 27.77 24.48 22.62 32.64 25.03
Piotroski F-Score
6 6 7 6 7 8 7 7 5 6
Altman Z-Score
3.25 3.61 3.73 3.61 3.60 4.21 3.91 3.78 3.48 2.84
P/S ratio
0.83 1.06 1.06 1.15 1.29 1.65 1.50 1.35 1.16 0.67
P/FCF ratio
19.00 18.42 17.58 17.06 16.54 23.81 20.76 19.49 22.50 18.65
Altman Z″-Score (non-manufacturers)
1.45 1.83 1.92 1.74 1.84 2.01 1.90 1.99 1.90 1.40
Beneish M-Score
(2.42) (2.52) (2.45) (2.43) (2.53) (2.46) (2.89) (1.60) (2.37) (2.41)
P/Operating CF
(109.08) (82.73) 100.13 45.06 54.55 147.15 (107.21) (96.38) 196.66 270.52
Dividend Safety Score
— — — — — — — — — 76
P/B ratio
4.03 4.28 4.42 4.63 4.87 6.31 5.97 5.30 4.74 2.99
Price to Tangible BV
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales
0.90 1.13 1.15 1.25 1.37 1.71 1.58 1.42 1.27 0.77
EV/EBITDA
11.09 12.98 13.16 13.49 13.90 18.17 16.10 14.56 13.99 14.75
EV/Operating CF
16.97 16.66 16.56 16.36 15.86 22.02 19.56 18.20 21.04 17.46
EV/FCF
20.54 19.58 19.06 18.43 17.48 24.74 21.90 20.60 24.59 21.40
Quick Ratio
0.59 0.62 0.61 0.58 0.62 0.66 0.51 0.69 0.75 0.70
Current Ratio
0.69 0.73 0.73 0.69 0.74 0.79 0.77 0.79 0.83 0.79
Net Debt/EBITDA
0.83 0.76 1.02 1.01 0.75 0.68 0.84 0.79 1.19 1.89
Debt/Assets
20.99% 20.74% 22.72% 21.17% 19.59% 19.97% 22.19% 21.29% 24.26% 23.36%
Debt/Equity
0.68 0.58 0.64 0.61 0.57 0.56 0.67 0.62 0.74 0.72
Asset Turnover
1.58 1.54 1.55 1.49 1.39 1.40 1.42 1.43 1.40 1.47
Operating CF/Net income
1.40 1.29 1.31 1.33 1.44 1.29 1.30 1.30 1.68 1.63
Capex/Depreciation
(0.83) (0.90) (0.85) (0.76) (0.71) (0.79) (0.82) (0.85) (0.85) (0.83)
Interest Coverage
12.12 12.82 12.39 11.55 13.47 14.44 13.59 9.97 8.27 4.74
ROE
19.52% 23.99% 23.02% 24.12% 23.92% 24.11% 25.71% 25.45% 14.95% 12.16%
ROA
6.00% 8.06% 8.23% 8.49% 8.30% 8.44% 8.79% 8.62% 5.04% 3.97%
ROIC
15.95% 15.05% 14.54% 14.82% 16.06% 16.02% 16.45% 16.43% 14.26% 8.21%
Return on Tangible Assets
(74.08%) (165.85%) (197.82%) (132.51%) (152.87%) (228.49%) (200.40%) (244.15%) (193.69%) (88.95%)
Average Days of Receivables
30.91 28.72 29.44 32.35 36.06 35.64 19.91 38.28 44.18 42.99
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Intangible Assets out of Total Assets
0.46 0.45 0.45 0.44 0.42 0.40 0.44 0.43 0.44 0.42
Share Based Compensation of Revenue
0.26% 0.30% 0.28% 0.29% 0.26% 0.28% 0.29% 0.28% 0.25% 0.22%
Graham Net Nets
(0.33) (0.24) (0.25) (0.25) (0.23) (0.16) (0.20) (0.20) (0.25) (0.40)
Graham Number
82.10 111.61 124.38 143.14 161.15 179.93 203.58 233.62 192.90 180.87
Earnings Yield
4.63% 4.84% 4.89% 4.87% 4.57% 3.60% 4.09% 4.42% 3.06% 4.00%
Free Cash Flow Yield
5.26% 5.43% 5.69% 5.86% 6.05% 4.20% 4.82% 5.13% 4.44% 5.36%
Revenue per Share
194.16 208.67 234.94 254.63 270.96 304.98 345.96 400.45 434.61 492.92
Operating CF per Share
10.29 14.10 16.32 19.41 23.37 23.69 27.97 31.32 26.28 21.69
Capex per Share
(1.79) (2.10) (2.14) (2.18) (2.16) (2.60) (2.99) (3.65) (3.80) (3.99)
Free Cash Flow per Share
8.50 12.01 14.17 17.24 21.20 21.09 24.98 27.67 22.48 17.70
Cash per Share
13.94 16.07 14.87 14.98 20.84 25.35 29.79 31.93 31.61 30.97
Shareholders Equity per Share
40.10 51.69 56.41 63.55 72.00 79.58 86.93 101.75 106.70 110.23
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
40.10 51.69 56.41 63.55 72.00 79.58 86.93 101.75 106.70 110.23
Free Cash Flow
8,090.00 11,573.00 13,650.00 16,392.00 20,123.00 19,889.00 23,404.00 25,682.00 20,705.00 16,075.00
Working Capital
(15,373.00) (13,379.00) (14,517.00) (19,148.00) (18,702.00) (16,534.00) (20,168.00) (20,617.00) (17,990.00) (24,315.00)
Capital Expenditures
(1,705.00) (2,023.00) (2,063.00) (2,071.00) (2,051.00) (2,454.00) (2,802.00) (3,386.00) (3,499.00) (3,622.00)
Net Current Asset Value
(50,754.00) (52,141.00) (59,210.00) (70,819.00) (75,243.00) (75,403.00) (95,186.00) (100,862.00) (114,231.00) (118,909.00)
EV/EBIT
12.85 14.90 15.00 15.35 15.70 20.53 18.03 16.35 15.77 18.14
Capex to Sales
0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Price to Operating Income
11.89 14.02 13.83 14.20 14.85 19.75 17.09 15.47 14.43 15.81
Other line items
Depreciation/Fixed assets
0.35 0.32 0.29 0.31 0.34 0.35 0.34 0.35 0.39 0.41
Cash ROIC
10.48% 12.29% 13.22% 14.70% 15.88% 14.07% 14.28% 14.09% 10.37% 8.02%
Accounts Receivable Turnover
12.76 12.78 13.28 12.20 10.97 10.75 14.17 13.12 9.16 8.85
Accounts Payable Turnover
11.16 10.80 10.81 10.34 9.16 9.25 9.34 9.41 9.38 10.08
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Days of Payables
34.48 35.94 35.37 37.59 43.18 41.27 41.37 41.56 40.31 38.07
Days of Inventory on Hand
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Receivables
14,487.50 15,740.50 17,040.00 19,856.00 23,433.00 26,743.00 22,881.50 28,325.50 43,712.00 50,584.50
Average Payables
12,677.50 14,270.50 15,942.50 17,855.00 20,750.00 23,569.00 26,179.00 29,836.50 33,147.50 36,184.50
Average Assets
117,032.00 130,934.00 145,639.50 163,055.00 185,589.00 204,747.50 228,955.50 259,712.50 285,999.00 303,929.50
Average Common Equity
35,951.00 44,005.00 52,076.00 57,377.50 64,382.00 71,686.50 78,247.50 87,935.50 96,344.50 99,179.00

Fold the line items

Columns are period end dates